# SpyGlass Pharma Inc. (SGP)

Source: https://www.quantisnow.com/company/SGP
Generated: 2026-11-06T21:39:34.753Z

- Ticker: SGP
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2026
- SEC CIK: 0001778922

## Latest SGP news and filings

- 2026-11-05 13:00 UTC [Conference Announcement] [SpyGlass Pharma to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/spyglass-pharma-to-participate-in-upcoming-investor-conferences-6774814)
- 2026-10-19 20:10 UTC [SEC Form 8-K] [SEC Form 8-K filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-spyglass-pharma-inc-6750617)
- 2026-10-19 12:00 UTC [SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System](https://www.quantisnow.com/insight/spyglass-pharma-announces-positive-4-year-data-from-first-in-human-trial-of-6750143)
- 2026-10-01 12:15 UTC [SEC Form 8-K] [SpyGlass Pharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/spyglass-pharma-inc-filed-sec-form-8-k-regulation-fd-disclosure-6731543)
- 2026-10-01 12:00 UTC [Mergers & Acquisitions] [SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability](https://www.quantisnow.com/insight/spyglass-pharma-acquires-advanced-vision-science-inc-avs-securing-scalable-6731467)
- 2026-09-02 12:00 UTC [Conference Announcement] [SpyGlass Pharma to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/spyglass-pharma-to-participate-in-upcoming-investor-conferences-6702342)
- 2026-08-14 12:24 UTC [Analyst Coverage Initiated] [Raymond James initiated coverage on SpyGlass Pharma with a new price target](https://www.quantisnow.com/insight/raymond-james-initiated-coverage-on-spyglass-pharma-with-a-new-6681960)
- 2026-08-06 20:37 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-spyglass-pharma-inc-6669659)
- 2026-08-06 20:16 UTC [SEC Form 8-K] [SpyGlass Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/spyglass-pharma-inc-filed-sec-form-8-k-results-of-operations-6669303)
- 2026-08-06 20:05 UTC [SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates](https://www.quantisnow.com/insight/spyglass-pharma-reports-second-quarter-2026-financial-results-and-provides-6668677)
- 2026-06-15 12:00 UTC [Leadership Update] [SpyGlass Pharma Appoints Shannon Treviño as General Counsel](https://www.quantisnow.com/insight/spyglass-pharma-appoints-shannon-trevio-as-general-counsel-6601853)
- 2026-06-02 12:00 UTC [Leadership Update] [SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing](https://www.quantisnow.com/insight/spyglass-pharma-appoints-mike-pinder-as-vice-president-marketing-6583274)
- 2026-05-21 12:00 UTC [Conference Announcement] [SpyGlass Pharma to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/spyglass-pharma-to-participate-in-upcoming-investor-conferences-6566402)
- 2026-05-18 12:00 UTC [SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System](https://www.quantisnow.com/insight/spyglass-pharma-announces-new-add-on-category-iii-cpt-code-for-6559166)
- 2026-05-14 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-spyglass-pharma-inc-6554407)
- 2026-05-14 20:15 UTC [SEC Form 8-K] [SpyGlass Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/spyglass-pharma-inc-filed-sec-form-8-k-results-of-operations-6554085)
- 2026-05-14 20:05 UTC [Public Offering] [SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates](https://www.quantisnow.com/insight/spyglass-pharma-reports-first-quarter-2026-financial-results-and-provides-6553655)
- 2026-03-26 21:23 UTC [SEC Form 10-K] [SEC Form 10-K filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-spyglass-pharma-inc-6471880)
- 2026-03-26 20:06 UTC [SEC Form 8-K] [SpyGlass Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/spyglass-pharma-inc-filed-sec-form-8-k-results-of-operations-6471024)
- 2026-03-26 20:05 UTC [Public Offering] [SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update](https://www.quantisnow.com/insight/spyglass-pharma-reports-fourth-quarter-and-full-year-2025-earnings-6470942)
- 2026-03-10 12:42 UTC [Analyst Coverage Initiated] [H.C. Wainwright initiated coverage on SpyGlass Pharma with a new price target](https://www.quantisnow.com/insight/hc-wainwright-initiated-coverage-on-spyglass-pharma-with-a-new-6438900)
- 2026-03-09 20:05 UTC [SEC Form 8-K] [SpyGlass Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/spyglass-pharma-inc-filed-sec-form-8-k-other-events-financial-6437062)
- 2026-03-09 12:00 UTC [SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System](https://www.quantisnow.com/insight/spyglass-pharma-announces-positive-topline-12-month-phase-12-trial-results-6436257)
- 2026-03-04 13:00 UTC [Conference Announcement] [SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit](https://www.quantisnow.com/insight/spyglass-pharma-to-participate-in-the-jefferies-biotech-on-the-6428421)
- 2026-03-03 13:31 UTC [Analyst Coverage Initiated] [Stifel initiated coverage on SpyGlass Pharma with a new price target](https://www.quantisnow.com/insight/stifel-initiated-coverage-on-spyglass-pharma-with-a-new-price-6424076)
- 2026-03-03 13:31 UTC [Analyst Coverage Initiated] [Citigroup initiated coverage on SpyGlass Pharma with a new price target](https://www.quantisnow.com/insight/citigroup-initiated-coverage-on-spyglass-pharma-with-a-new-price-6424073)
- 2026-03-03 13:31 UTC [Analyst Coverage Initiated] [Jefferies initiated coverage on SpyGlass Pharma with a new price target](https://www.quantisnow.com/insight/jefferies-initiated-coverage-on-spyglass-pharma-with-a-new-price-6424072)
- 2026-03-03 13:31 UTC [Analyst Coverage Initiated] [Leerink Partners initiated coverage on SpyGlass Pharma with a new price target](https://www.quantisnow.com/insight/leerink-partners-initiated-coverage-on-spyglass-pharma-with-a-new-6424071)
- 2026-02-18 00:23 UTC [SEC Form SCHEDULE 13G filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-spyglass-pharma-inc-6397631)
- 2026-02-18 00:21 UTC [SEC Form SCHEDULE 13D filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13d-filed-by-spyglass-pharma-inc-6397625)
- 2026-02-13 23:21 UTC [SEC Form SCHEDULE 13D filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13d-filed-by-spyglass-pharma-inc-6393469)
- 2026-02-13 21:05 UTC [SEC Form SCHEDULE 13D filed by SpyGlass Pharma Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13d-filed-by-spyglass-pharma-inc-6392130)
- 2026-02-13 21:01 UTC [SEC Form 8-K] [SpyGlass Pharma Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/spyglass-pharma-inc-filed-sec-form-8-k-leadership-update-6392037)
- 2026-02-11 22:15 UTC [Insider Buy] [Director Ra Capital Management, L.P. converted options into 4,331,117 shares and bought $59,040,000 worth of shares (3,690,000 units at $16.00) (SEC Form 4)](https://www.quantisnow.com/insight/director-ra-capital-management-lp-converted-options-into-4331117-shares-6387330)
- 2026-02-11 22:13 UTC [SEC Form 4] [Amendment: SEC Form 4 filed by Director Nielsen Kirk G.](https://www.quantisnow.com/insight/amendment-sec-form-4-filed-by-director-nielsen-kirk-g-6387319)
- 2026-02-11 21:30 UTC [Insider Buy] [Large owner Florence Anthony A. Jr. converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-florence-anthony-a-jr-converted-options-into-6454801-6386974)
- 2026-02-11 21:30 UTC [Insider Buy] [Director Behbahani Ali converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)](https://www.quantisnow.com/insight/director-behbahani-ali-converted-options-into-6454801-shares-and-bought-6386971)
- 2026-02-11 21:30 UTC [Insider Buy] [Large owner Yang Rick converted options into 5,097,538 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-yang-rick-converted-options-into-5097538-shares-and-6386970)
- 2026-02-11 21:30 UTC [Insider Buy] [Large owner Baskett Forest converted options into 6,454,801 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-baskett-forest-converted-options-into-6454801-shares-and-6386963)
- 2026-02-11 21:30 UTC [Insider Buy] [Large owner New Enterprise Associates 17, L.P. converted options into 5,097,538 shares and bought $15,000,000 worth of shares (937,500 units at $16.00) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-new-enterprise-associates-17-lp-converted-options-into-6386962)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SGP
- Earnings history: https://www.quantisnow.com/earnings/SGP
- Dividend history: https://www.quantisnow.com/dividends/SGP
- Insider transactions: https://www.quantisnow.com/insiders/SGP
- Options chain: https://www.quantisnow.com/options/SGP
- SEC 8-K filings only: https://www.quantisnow.com/company/SGP/8-k
- RSS and alerts for SGP: https://www.quantisnow.com/docs/rss-feeds.md